Clinical Trials Directory

Trials / Completed

CompletedNCT04664296

COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor)

Epidemiology of CoV-2 SARS Infections: Dynamics of Community Contamination in Children and Adults

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

Unlike other respiratory viruses such as influenza and Respiratory Syncytial Virus (RSV) where the child is the essential reservoir and central vector of intrafamilial contamination, the child is likely to be a small player in the transmission of Severe Acute Respiratory Syndrome CoronaVirus 2 (SRAS-CoV2) infection. This study aims to describe the age category of the first contact, within 14 days before the appearance of the first symptoms of the index case in order to describe the age categories of this first contaminant, globally, in the group of children and finally in the group of adults. This work is intended to provide food for discussion and to justify the distancing and containment measures imposed on children when their isolation has a deleterious impact that has now been established for some children.

Conditions

Interventions

TypeNameDescription
OTHERReview of medical patient fileReview of medical patient file, including patient tracing, brief summary of the disease course, barrier gestures, social distancing.
OTHERPhone call interviewless than 15 minutes phone call

Timeline

Start date
2020-12-21
Primary completion
2021-03-23
Completion
2021-03-23
First posted
2020-12-11
Last updated
2021-04-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04664296. Inclusion in this directory is not an endorsement.